Clearmind Medicine Inc. Proceeds From Exercise Of Warrants
Clearmind Medicine Inc. (CMND) reported Proceeds From Exercise Of Warrants of $183.12 thousand for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Cash Flow › Financing Activities
ifrs-full:ProceedsFromExerciseOfWarrants · last filed 2026-03-12
- Clearmind Medicine Inc. proceeds from exercise of warrants for the quarter ending 2023-01-31 was 8.47M CAD.
CAD
| Period end | Proceeds From Exercise Of Warrants 3 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|
| 2023-10-31 | 1.80K CAD 20-F/A · filed 2024-03-18 | |
| 2023-01-31 | 8.47M CAD 6-K · filed 2023-03-17 | |
| 2022-10-31 | 795.13K CAD 20-F · filed 2023-02-06 | |
| 2021-10-31 | 7.36M CAD 20-F · filed 2023-02-06 | |
| 2020-10-31 | 598.70K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Proceeds From Exercise Of Warrants | Proceeds From Exercise Of Warrants 3 month | Proceeds From Exercise Of Warrants 6 month | Proceeds From Exercise Of Warrants 9 month | Proceeds From Exercise Of Warrants 12 month |
|---|---|---|---|---|---|
| 2026-01-31 | $183.12K 6-K · filed 2026-03-12 | $183.12K derived: sum of 2 quarters · filed 2026-03-12 | $183.12K derived: sum of 3 quarters · filed 2026-03-12 | $183.12K derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-11-14 | $183.12K 6-K · filed 2026-03-12 | ||||
| 2025-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $0.00 derived: sum of 2 quarters · filed 2026-01-20 | $0.00 derived: sum of 3 quarters · filed 2026-01-20 | $415.09K 20-F · filed 2026-01-20 | |
| 2025-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $0.00 derived: sum of 2 quarters · filed 2025-09-11 | $415.09K 6-K · filed 2025-09-11 | $484.04K derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-04-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $415.09K 6-K · filed 2025-06-12 | $484.04K derived: sum of 3 quarters · filed 2026-03-12 | $863.66K derived: sum of 4 quarters · filed 2026-03-12 | |
| 2025-01-31 | $415.09K 6-K · filed 2026-03-12 | $484.04K derived: sum of 2 quarters · filed 2026-03-12 | $863.66K derived: sum of 3 quarters · filed 2026-03-12 | $1.02M derived: sum of 4 quarters · filed 2026-03-12 | |
| 2024-10-31 | $68.95K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $448.57K derived: sum of 2 quarters · filed 2026-01-20 | $606.49K derived: sum of 3 quarters · filed 2026-01-20 | $4.10M 20-F · filed 2026-01-20 | |
| 2024-07-31 | $379.62K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $537.54K derived: sum of 2 quarters · filed 2025-09-11 | $4.04M 6-K · filed 2025-09-11 | ||
| 2024-04-30 | $157.92K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $3.66M 6-K · filed 2025-06-12 | |||
| 2024-01-31 | $3.50M 6-K · filed 2025-03-13 | ||||
| 2023-10-31 | $590.08K 20-F · filed 2026-01-20 | ||||
| 2023-04-30 | $2.96M 6-K · filed 2023-06-14 |